The WSJ Health Blog finally picks up on funny Lipitor numbers
I explained the unusual Pfizer Inc quarterly report in my story Pfizer profit down 48%, but lets put some lipstick on that pig!, on July 18. In this post I addressed the unusual explanation for a sudden 25% drop in Lipitor sales.
So I was happy to note that the following day, the WSJ Health Blog picked up on where I left off; read more in WSJ's Inventory Bugaboos Dog and Aid Drug Makers from July 19.
I do note that the WSJ blog coverage of Pfizer's report on July 18, Pfizer Earnings Fall as Lipitor Crumbles, didn't have any of this analysis, and uncritically pretty much reported the company press release.